Adverse health effects of testosterone deficiency (TD) in men

Steroids

Volumn 88, Issue , 2014, Pages 106-116

  Traish, Abdulmaged M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Erectile dysfunction; Mortality; Testosterone; Testosterone deficiency; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE;

ADVERSE OUTCOME; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; BONE DENSITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; COMORBIDITY; DYSLIPIDEMIA; EJACULATION; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; FAT MASS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOGONADISM; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; METABOLIC SYNDROME X; MOOD; MORTALITY; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; QUALITY OF LIFE; REVIEW; SEXUAL FUNCTION; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; DEFICIENCY; HEALTH; MALE;

COMORBIDITY; HEALTH; HUMANS; MALE; TESTOSTERONE;

EID: 84907597502     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2014.05.010     Document Type: Review

References (223)

1. J. Buvat, M. Maggi, A. Guay, and L.O. Torres Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment J Sex Med 10 2013 245 284
2. C. Wang, E. Nieschlag, R. Swerdloff, H.M. Behre, W.J. Hellstrom, L.J. Gooren, J.M. Kaufman, J.J. Legros, B. Lunenfeld, A. Morales, J.E. Morley, C. Schulman, I.M. Thompson, W. Weidner, and F.C. Wu Investigation, treatment and monitoring of late onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations Eur J Endocrinol 159 2008 507 514
3. S. Bhasin, G.R. Cunningham, F.J. Hayes, A.M. Matsumoto, P.J. Snyder, R.S. Swerdloff, and V.M. Montori Testosterone therapy in men with Androgen deficiency syndromes: An endocrine society clinical practice guideline J Clin Endocrinol Metab 95 2010 2536 2559
4. J. Buvat, M. Maggi, L. Gooren, A.T. Guay, J.M. Kaufman, A. Morgentaler, C. Schulman, H.M. Tan, L.O. Torres, A. Yassin, and M. Zitzmann Endocrine aspects of male sexual dysfunctions J Sex Med 7 2010 1627 1656
5. F.C. Wu, A. Tajar, J.M. Beynon, S.R. Pye, A.J. Silman, J.D. Finn, T.W. O'Neill, G. Bartfai, F.F. Casanueva, G. Forti, A. Giwercman, T.S. Han, K. Kula, M.E.J. Lea, N. Pendleton, M. Punab, S. Boonen, D. Vanderschueren, F. Labrie, and I. Huhtaniemi EMAS Group. Identification of late-onset hpogonadism in middle-aged and elderly men N Engl J Med 363 2010 123 135
6. A.M. Traish, M.M. Miner, A. Morgentaler, and M. Zitzmann Testosterone deficiency Am J Med 124 2011 578 587
7. A.B. Araujo, A.B. O'Donnell, D.J. Brambilla, W.B. Simpson, C. Longcope, A.M. Matsumoto, and J.B. McKinlay Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study J Clin Endocrinol Metab 89 2004 5920 5926
8. S.M. Harman, E.J. Metter, J.D. Tobin, J. Pearson, and M.R. Blackman Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging J Clin Endocrinol Metab 86 2001 724 731
9. T. Mulligan, M.F. Frick, Q.C. Zuraw, A. Stemhagen, and C. McWhirter Prevalence of hypogonadism in males aged at least 45 years: the HIM study Int J Clin Pract 60 2006 762 769
10. F.C. Wu, A. Tajar, S.R. Pye, A.J. Silman, J.D. Finn, T.W. O'Neill, G. Bartfai, F. Casanueva, G. Forti, A. Giwercman, I.T. Huhtaniemi, K. Kula, M. Punab, S. Boonen, and D. Vanderschueren European Male Aging Study Group. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study J Clin Endocrinol Metab 93 2008 2737 2745
11. A. Guay, A.D. Seftel, and A. Traish Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses Int J Impot Res 22 2010 9 19
12. S.A. Hall, G.R. Esche, A.B. Araujo, T.G. Travison, R.V. Clark, R.E. Williams, and J.B. McKinlay Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample J Clin Endocrinol Metab 93 2008 3870 3877
13. E.L. Ding, Y. Song, V.S. Malik, and S. Liu Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis JAMA 295 2006 1288 1299
14. D. Kapoor, H. Aldred, S. Clark, K. Channer, and T. Jones Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes Diabetes Care 30 2007 911 917
15. D. Kapoor, E. Goodwin, K.S. Channer, and T.H. Jones Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes Eur J Endocrinol 154 2006 899 906
16. S. Dhindsa, S. Prabhakar, M. Sethi, A. Bandyopadhyay, A. Chaudhuri, and P. Dandona Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes J Clin Endocrinol Metab 89 2004 5462 5468
17. J. Svartberg, D. von Mühlen, J. Sundsfjord, and R. Jorde Waist circumference and testosterone levels in community dwelling men. The Tromsø study Eur J Epidemiol 19 2004 657 663
18. S. Dhindsa, M.G. Miller, C.L. McWhirter, D.E. Mager, H. Ghanim, A. Chaudhuri, and P. Dandona Testosterone concentrations in diabetic and nondiabetic obese men Diabetes Care 33 2010 1186 1192
19. G. Corona, E. Mannucci, R. Mansani, L. Petrone, M. Bartolini, R. Giommi, G. Forti, and M. Maggi Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus Eur Urol 46 2004 222 228
20. E.M. Camacho, I.T. Huhtaniemi, T.W. O'Neill, J.D. Finn, S.R. Pye, D.M. Lee, A. Tajar, G. Bartfai, S. Boonen, F.F. Casanueva, G. Forti, A. Giwercman, T.S. Han, K. Kula, B. Keevil, M.E. Lean, N. Pendleton, M. Punab, D. Vanderschueren, and F.C. Wu EMAS Group age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study Eur J Endocrinol 168 2013 445 455
21. Z. Shi, A.B. Araujo, S. Martin, P. O'Loughlin, and G.A. Wittert Longitudinal changes in testosterone over five years in community-dwelling men J Clin Endocrinol Metab 98 2013 3289 3297
22. B.B. Yeap, A.B. Araujo, and G.A. Wittert Do low testosterone levels contribute to ill-health during male ageing? Crit Rev Clin Lab Sci 49 2012 168 182
23. A.B. Araujo, J.M. Dixon, E.A. Suarez, M.H. Murad, L.T. Guey, and G.A. Wittert Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis J Clin Endocrinol Metab 96 2011 3007 3019
24. J. Hofstra, S. Loves, B. van Wageningen, J. Ruinemans-Koerts, I. Jansen, and H. de Boer High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment Neth J Med 66 2008 103 109
25. S.K. Singh, R. Goyal, and D.D. Pratyush Is hypoandrogenemia a component of metabolic syndrome in males? Exp Clin Endocrinol Diabetes 119 2011 30 35
26. C. Couillard, J. Gagnon, J. Bergeron, A.S. Leon, D.C. Rao, J.S. Skinner, J.H. Wilmore, J.P. Després, and C. Bouchard Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study J Clin Endocrinol Metab 85 2000 1026 1031
27. K. Blouin, J.P. Despres, C. Couillard, A. Tremblay, D. Prud'homme, C. Bouchard, and A. Tchernof Contribution of age and declining androgen levels to features of the metabolic syndrome in men Metabolism 54 2005 1034 1040
28. K. Blouin, C. Richard, G. Brochu, F.S. Hould, S. Lebel, S. Marceau, S. Biron, V. Luu-The, and A. Tchernof Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men J Endocrinol. 191 2006 637 649
29. G. Corona, M. Monami, G. Rastrelli, A. Aversa, Y. Tishova, F. Saad, A. Lenzi, G. Forti, E. Mannucci, and M. Maggi Testosterone and metabolic syndrome: a meta-analysis study J Sex Med 8 2011 272 283
30. D.E. Laaksonen, L. Niskanen, K. Punnonen, K. Nyyssonen, T.P. Tuomainen, R. Salonen, R. Rauramaa, and J.T. Salonen Sex hormones, inflammation and the metabolic syndrome: a population-based study Eur J Endocrinol 149 2003 601 608
31. V. Kupelian, G.R. Chiu, A.B. Araujo, R.E. Williams, R.V. Clark, and J.B. McKinley Association of sex hormones and C-reactive protein levels in men Clin Endocrinol 72 2010 527 533
32. Y. Zhang, Y. Gao, A. Tan, X. Yang, H. Zhang, S. Zhang, C. Wu, Z. Lu, M. Wang, M. Liao, X. Qin, L. Li, Y. Hu, and Z. Mo Endogenous sex hormones and C-reactive protein in healthy Chinese men Clin Endocrinol 78 2013 60 66
33. D. Kapoor, S. Clarke, R. Stanworth, K.S. Channer, and T.H. Jones The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes Eur J Endocrinol 156 2007 595 602
34. V. Bhatia, A. Chauhuri, R. Tomar, S. Dhindsa, H. Ghanim, and P. Dandona Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetics Diabetes Care 29 2006 2289 2294
35. N. Guler, T. Batyraliev, H. Dulger, C. Ozkara, M. Tuncer, S. Aslan, H. Okut, and M. Agirbasli The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting Int J Cardiol 109 2006 339 343
36. A. Aversa, R. Bruzziches, D. Francomano, G. Rosano, A.M. Isidori, A. Lenzi, and G. Spera Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study J Sex Med 7 2010 3495 3503
37. C.J. Malkin, P.J. Pugh, R.D. Jones, D. Kapoor, K.S. Channer, and T.H. Jones The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profile in hypogonadal men J Clin Endocrinol Metab 89 2004 3313 3318
38. I. Van Pottelbergh, L. Braeckman, D.D. Bacquer, G. De Backer, and J.M. Kaufman Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men Atherosclerosis 166 2003 95 102
39. M. Maggio, S. Basaria, A. Ble, F. Lauretani, S. Bandinelli, G.P. Ceda, G. Valenti, S.M. Ling, and L. Ferrucci Correlation between testosterone and inflammatory marker soluble interleukin-6 receptor in older men J Clin Endocrinol Metab 91 2006 345 347
40. H.R. Nakhai Pour, D.E. Grobbee, M. Muller, and Y.T. van der Schouw Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men Clin Endocrinol 66 2007 394 398
41. R. Haring, S.E. Baumeister, H. Volzke, M. Dorr, T. Kocher, M. Nauck, and H. Wallaschofski Prospective inverse association of sex hormone concentrations in men with biomarkers of inflammation and oxidative stress J Androl 33 2012 944 950
42. R. Steinbrook Facing the diabetes epidemic-mandatory reporting of glycosylated hemoglobin values in New York city N Engl J Med. 354 2006 545 548
43. N.I. Parikh, M.J. Pencine, T.J. Wang, K.J. Lanier, C.S. Fox, R.B. d'Agostino, and S.V. Ramachandran Increasing trends in incidence of overweight and obesity over 5 decades Am J Med 120 2007 242 250
44. J.Y. Oh, E. Barrett-Connor, and N.M. Wedick Wingard DL; Rancho Bernardo Study. Endogenous sex hormones and the development of type 2 diabetes in older men and women; the Rancho Bernardo study Diabetes Care 25 2002 55 60
45. M.M. Shores, A.M. Matsumoto, K.L. Sloan, and D.R. Kivlahan Low serum testosterone and mortality in male veterans Arch Intern Med 166 2006 1660 1665
46. E. Selvin, M. Feinleib, L. Zhang, S. Rohrmann, N. Rifai, W. Nelson, A. Dobs, S. Basaria, S. Golden, and E. Platz Androgens and diabetes in men Diabetes Care 30 2007 234 238
47. R.K. Stellato, H.A. Feldman, O. Hamdy, E.S. Horton, and J.B. McKinlay Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study Diabetes Care 23 2000 490 494
48. E.L. Rhoden, E.P. Ribeiro, C.E. Riedner, C. Teloken, and C.A. Souto Glycosylated haemoglobin levels and the severity of erectile function in diabetic men BJU Int 95 2005 615 617
49. E.L. Rhoden, D.P. Ribeiro, C. Teloken, and C.A. Souto Diabetes mellitus is associated with subnormal serum levels of free testosterone in men BJU Int 96 2005 867 870
50. S.M. Haffner, H. Miettinen, P. Karhapää, L. Mykkänen, and M. Laakso Leptin concentrations, sex hormones, and cortisol in nondiabetic men J Clin Endocrinol Metab 82 1997 1807 1809
51. M. Grossmann, M.C. Thomas, S. Panagiotopoulos, K. Sharpe, R.J. Macisaac, S. Clarke, J.D. Zajac, and G. Jerums Low testosterone levels are common and associated with insulin resistance in men with diabetes J Clin Endocrinol Metab 93 2008 1834 1840
52. M. Fukui, Y. Kitagawa, N. Nakamura, M. Kadono, S. Mogami, C. Hirata, N. Ichio, K. Wada, G. Hasegawa, and T. Yoshikawa Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes Diabetes Care 26 2003 1869 1873
53. M. Fukui, Y. Kitagawa, H. Ose, G. Hasegawa, T. Yoshikawa, and N. Nakamura Role of endogenous androgen against insulin resistance and atherosclerosis in men with type 2 diabetes Curr Diabetes Rev 3 2007 25 31
54. D. Simon, M.A. Charles, K. Nahoul, G. Orssaud, J. Kremski, V. Hully, E. Joubert, L. Papoz, and E. Eschwege Assocation between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study J Clin Endocrinol Metab 82 1997 682 685
55. B. Andersson, P. Marin, L. Lissner, A. Vermeulen, and P. Bjorntorp Testosterone concentrations in women and men with NIDDM Diabetes Care 17 1994 405 411
56. N. Pitteloud, M. Hardin, A.A. Dwyer, E. Valassi, M. Yialamas, D. Elahi, and F.J. Hayes Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men J Clin Endocrinol Metab 90 2005 2636 2641
57. N. Pitteloud, V.K. Mootha, A.A. Dwyer, M. Hardin, H. Lee, K.F. Eriksson, D. Tripathy, M. Yialamas, L. Groop, D. Elahi, and F.J. Hayes Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men Diabetes Care 28 2005 1636 1642
58. J.A. Osuna, R. Gomez-Perez, G. Arata-Bellabarba, and V. Villaroel Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men Arch Androl 52 2006 355 361
59. S. Basaria, D.C. Muller, M.A. Carducci, J. Egan, and A.S. Dobs Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy Cancer 106 2006 581 588
60. G. Corona, E. Mannucci, L. Petrone, C. Schulman, G. Balercia, A.D. Fisher, V. Chiarini, G. Forti, and M. Maggi A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction J Sex Med 4 2007 789 796
61. G. Corona, E. Mannucci, L. Petrone, G. Balercia, F. Paggi, A.D. Fisher, F. Lotti, V. Chiarini, D. Fedele, G. Forti, and M. Maggi NCEP-ATPIII-Defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction J Sex Med 4 2007 1038 1045
62. R. Pasquali, F. Casimirri, S. Cantobelli, N. Melchionda, A.M. Morselli Labate, R. Fabbri, M. Capelli, and L. Bortoluzzi Effect of obesity and body fat distribution on sex hormones and insulin in men Metabolism 40 1991 101 104
63. R. Pasquali, C. Macor, V. Vicennati, F. Novo, R. De lasio, P. Mesini, S. Boschi, F. Casimirri, and R. Vettor Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men Metabolism 46 1997 526 529
64. M. Muller, D.E. Grobbee, I. den Tonkelaar, S.W. Lamberts, and Y.T. van der Schouw Endogenous sex hormones and metabolic syndrome in aging men J Clin Endocrinol Metab 90 2005 2618 2623
65. A.M. Isidori, M. Caprio, F. Strollo, C. Moretti, G. Frajese, A. Isidori, and A. Fabbri Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels J Clin Endocrinol Metab 84 1999 3673 3680
66. A.M. Isidori, F. Strollo, M. More, M. Caprio, A. Aversa, C. Moretti, G. Frajese, G. Riondino, and A. Fabbri Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights J Clin Endocrinol Metab 85 2000 1954 1962
67. D.E. Laaksonen, L. Niskanen, K. Punnonen, K. Nyyssonen, T.P. Tuomainen, V.P. Valkonen, and J.T. Salonen The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study J Clin Endocrinol Metab 90 2005 712 719
68. U. Pagotto, A. Gambineri, C. Pelusi, S. Genghini, M. Cacciari, B. Otto, T. Castaneda, M. Tschop, and R. Pasquali Testosterone replacement therapy restores normal ghrelin in hypogonadal men J Clin Endocrinol Metab 88 2003 4139 4143
69. E.C. Tsai, A.M. Matsumoto, W.Y. Fujimoto, and E.J. Boyko Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat Diabetes Care 27 2004 861 868
70. P.M. Rao, D.M. Kelly, and T.H. Jones Testosterone and insulin resistance in the metabolic syndrome and T2DM in men Nat Rev Endocrinol 9 2013 479 493
71. M.A. Yialamas, A.A. Dwyer, E. Hanley, H. Lee, N. Pitteloud, and F.J. Hayes Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism J Clin Endocrinol Metab 92 2007 4254 4259
72. B.B. Yeap, S.A. Chubb, Z. Hyde, K. Jamrozik, G.J. Hankey, L. Flicker, and P.E. Norman Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study Eur J Endocrinol 161 2009 591 598
73. K.B. Rubinow, C. Tang, A.N. Hoofnagle, C.N. Snyder, J.K. Amory, J.W. Heinecke, and S.T. Page Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men Steroids 77 2012 454 460
74. M.R. Smith, S. Bennett, L. Evans, H. Kynaton, M. Parmar, M. Mason, J. Cockcroft, M. Scanlon, and J. Davies The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer J Clin Endocrinol Metab 86 2001 4261 4267
75. F. Dockery, C.J. Bulpitt, S. Agarwal, M. Donaldson, and C. Rajkumar Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia Clin Sci 104 2003 195 201
76. T. Nishiyama, F. Ishizaki, T. Anraku, H. Shimura, and K. Takahashi The influence of androgen deprivation therapy on metabolism in patients with prostate cancer J Clin Endocrinol Metab 90 2005 657 660
77. S. Shahani, M. Braga-Basaria, and S. Basaria Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis J Clin Endocrinol Metab 93 2008 2042 2049
78. M.J. Lage, B.L. Barber, and R.A. Markus Association of androgen-deprivation therapy and incidence of diabetes among males with prostate cancer Urology 70 2007 1104 1108
79. I.H. Derweesh, C.J. Diblasio, M.C. Kincade, J.B. Malcolm, K.D. Lamar, A.L. Patterson, A.E. Kitabchi, and R.W. Wake Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer BJU Int 100 2007 1060 1065
80. N.L. Keating, A.J. O'Malley, and M.R. Smith Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer J Clin Oncol 24 2006 4448 4456
81. S.M. Haffner, J. Shaten, M.P. Stern, G.D. Smith, and L. Kuller Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial Am J Epidemiol 143 1996 889 897
82. D.E. Laaksonen, L. Niskanen, K. Punnonen, K. Nyyssönen, T.P. Tuomainen, V.P. Valkonen, R. Salonen, and J.T. Salonen Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men Diabetes Care 27 2004 1036 1041
83. G. Corona, M. Monami, G. Rastrelli, A. Aversa, A. Sforza, A. Lenzi, G. Forti, E. Mannucci, and M. Maggi Type 2 diabetes mellitus and testosterone: a metaanalysis study Int J Androl 34 2010 528 540
84. L.A. Colangelo, P. Ouyang, K. Liu, P. Kopp, S.H. Golden, A. Dobs, M. Szklo, D. Vaidya, M. Cushman, and S.M. Gapstur Association of endogenous sex hormones with diabetes and impaired fasting glucose in men Diabetes Care 32 2009 1049 1051
85. T. Vikan, H. Schirmer, I. Njolstad, and J. Svartberg Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men Eur J Endocrinol 162 2010 747 754
86. T.H. Jones, S. Arver, H.M. Behre, J. Buvat, E. Meuleman, I. Moncada, A.M. Morales, M. Volterrani, A. Yellowlees, J.D. Howell, and K.S. Channer TIMES2 Investigators. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 Study) Diabetes Care 34 2011 828 837
87. A.E. Heufelder, F. Saad, M.C. Bunck, and L. Gooren Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone J Androl 30 2009 726 733
88. S. Firtser, M. Juonala, C.G. Magnussen, A. Jula, B.M. Loo, J. Marniemi, J.S. Viikari, J. Toppari, A. Perheentupa, N. Hutri-Kähönen, and O.T. Raitakari Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The Cardiovascular Risk in Young Finns Study Atherosclerosis 222 2012 257 262
89. R.D. Stanworth, D. Kapoor, K.S. Channer, and T.H. Jones Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes Clin Endocrinol 74 2011 624 630
90. I. Agledahl, J.B. Hansen, and J. Svartberg Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels Scand J Clin Lab Invest 68 2008 641 648
91. A.K. Monroe, and A.S. Dobs The effect of androgens on lipids Curr Opin Endocrinol Diabetes Obes 20 2013 132 139
92. B.P. Jiann, J.T. Hsieh, S.P. Liu, S.H. Hsu, and H.C. Wu Associations of endogenous testosterone and lipid profiles in middle-aged to older Taiwanese men Int J Impot Res 23 2011 62 69
93. J.M. Zmuda, J.A. Cauley, A. Kriska, N.W. Glynn, J.P. Gutai, and L.H. Kuller Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants Am J Epidemiol 146 1997 609 617
94. I. Agledahl, P.A. Skjaerpe, J.B. Hansen, and J. Svartberg Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study Nutr Metab Cardiovasc Dis 18 2008 256 262
95. M.R. Smith, J.S. Finkelstein, F.J. McGovern, A.L. Zietman, M.A. Fallon, D.A. Schoenfeld, and P.W. Kantoff Changes in body composition during androgen deprivation therapy for prostate cancer J Clin Endocrinol Metab 87 2002 599 603
96. M.R. Smith, H. Lee, and D.M. Nathan Insulin sensitivity during combined androgen blockade for prostate cancer J Clin Endocrinol Metab 91 2006 1305 1308
97. K.C. Chen, C.C. Peng, H.M. Hsieh, C.H. Peng, C.L. Hsieh, C.N. Huang, C.C. Chyau, H.E. Wang, and R.Y. Peng Antiandrogenic therapy can cause coronary arterial disease Int J Urol 12 2005 886 891
98. A. Haider, A. Yassin, F. Saad, and R. Shabsigh Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes Aging Male 10 2007 189 196
99. F. Saad, L.J. Gooren, A. Haider, and A. Yassin A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate J Androl 29 2008 102 105
100. A.M. Traish, and A. Galoosian Androgens modulate endothelial function and endothelial progenitor cells in erectile physiology Korean J Urol 54 2013 721 731
101. A.M. Traish, H. Abu-Zahra, and A.T. Guay The brain, the penis and steroid hormones: clinical correlates with endothelial dysfunction Curr Pharm Des 14 2008 3723 3736
102. Y.L. Lu, L. Kuang, H. Zhu, H. Wu, X.F. Wang, Y.P. Pang, N.J. Wang, and D.L. Yu Changes in aortic endothelium ultrastructure in male rats following castration, replacement with testosterone and administration of 5alpha-reductase inhibitor Asian J Androl 9 2007 843 847
103. D.M. Kelly, and T.H. Jones Testosterone: a vascular hormone in health and disease J Endocrinol 217 2013 R47 R71
104. A.E. Campelo, P.H. Cutini, and V.L. Massheimer Testosterone modulates platelet aggregation and endothelial cell growth through nitric oxide pathway J Endocrinol 213 2012 77 87
105. L. Goglia, V. Tosi, A.M. Sanchez, M.I. Flamini, X.D. Fu, S. Zullino, A.R. Genazzani, and T. Simoncini Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo Mol Hum Reprod 16 2010 761 769
106. J. Yu, M. Akishita, M. Eto, S. Ogawa, B.K. Son, S. Kato, Y. Ouchi, and T. Okabe Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/akt pathway Endocrinology 151 2010 1822 1828
107. P.J. Ong, G. Patrizi, W.C. Chong, C.M. Webb, C.S. Hayward, and P. Collins Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease Am J Cardiol 85 2000 269 272
108. M. Akishita, M. Hashimoto, Y. Ohike, S. Ogawa, K. Iijima, M. Eto, and Y. Ouchi Low Testosterone Level Is an Independent Determinant of Endothelial Dysfunction in Men Hypertens Res 30 2007 1029 1034
109. S.M. Kang, Y. Jang, Ji. Kim, N. Chung, S.Y. Cho, J.S. Chae, and J.H. Lee Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease Am J Cardiol 89 2002 862 864
110. K. Empen, R. Lorbeer, M. Dörr, R. Haring, M. Nauck, S. Gläser, A. Krebs, T. Reffelmann, R. Ewert, H. Völzke, H. Wallaschofski, and S.B. Felix Association of Testosterone Levels With Endothelial Function in Men: Results From a Population-Based Study Arterioscler Thromb Vasc Biol 32 2011 481 486
111. M. Perusquia, and J.N. Stallone Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites AJP Heart Circ Physiol 298 2010 H1301 H1307
112. J. Svartberg, D. von Mühlen, H. Schirmer, E. Barrett-Connor, J. Sundfjord, and R. Jorde Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study Eur J Endocrinol 150 2004 65 71
113. R.K. Bhattacharya, M. Khera, G. Blick, H. Kushner, D. Nguyen, and M.M. Miner Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS) BMC Endocr Disord 11 2011 18 29
114. M.A. Boyanov, Z. Boneva, and V.G. Christov Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency Aging Male 6 2003 1 7
115. J.Y. Li, J.C. Zhu, J.T. Dou, W.J. Bai, S.M. Deng, M. Li, W. Huang, and H. Jin Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study Aging Male 5 2002 47 51
116. R. Fogari, P. Preti, A. Zoppi, E. Fogari, A. Rinaldi, L. Corradi, and A. Mugellini Serum testosterone levels and arterial blood pressure in the elderly Hypertens Res 28 2005 625 630
117. Traish AM, Haider A, Doros G, Saad F. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract. 2013 (in press).
118. A. Haider, F. Saad, G. Doros, and L. Gooren Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study Obes Res Clin Prac 2013
119. F. Saad, A. Haider, G. Doros, and A. Traish Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss Obesity (Silver Spring) 21 2013 1975 1981
120. J.F. Reckelhoff Gender differences in the regulation of blood pressure Hypertension 37 2001 1199 1208
121. R.K. Dubey, S. Oparil, B. Imthum, and E.K. Jackson Sex hormones and hypertension Cardiovasc Res 53 2002 688 708
122. D.M. Kelly, and T.H. Jones Testosterone: a metabolic hormone in health and disease J Endocrinol 217 2013 R25 R45
123. J. Makinen, M. Jarvisalo, P. Pollanen, A. Perheentupa, K. Irjala, M. Koskenvuo, J. Makinen, I. Huhtaniemi, and O. Raitakari Increased carotid atherosclerosis in andropausal middle-aged men J Am Coll Cardiol 45 2005 1603 1608
124. A.W. van den Beld, M.L. Bots, J.A.M.L.L. Janssen, H.A.P. Pols, S.W.J. Lamberts, and D.E. Grobbee Endogenous hormones and carotid atherosclerosis in elderly men Am J Epidemiol 157 2003 25 31
125. G. De Pergola, N. Pannacciulli, M. Ciccone, M. Tartagni, P. Rizzon, and R. Giorgino Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men Int J Obes Relat Metab Disord 27 2003 803 807
126. L. Fu, Q.P. Gao, and J.X. Shen Relationship between testosterone and indexes indicating endothelial function in male coronary heart disease patients Asian J Androl 10 2008 214 218
127. J. Svartberg, D. Von Muhlen, E. Mathiesen, O. Joakimsen, K.H. Bonaa, and E. Stensland-Bugge Low testosterone levels are associated with carotid atherosclerosis in men J Intern Med 259 2006 576 582
128. T. Vikan, S.H. Johnsen, H. Schirmer, I. Njolstad, and J. Svartberg Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromso study Eur J Epidemiol 24 2009 289 295
129. A.E. Hak, J.C.M. Witteman, F.H. De Jong, M.I. Geerkings, A. Hofman, and H.A.P. Pols Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam Study J Clin Endocrinol Metab 87 2002 3623 3639
130. M. Muller, A.W. van den Beld, M.L. Bots, D.E. Grobbee, S.W.J. Lamberts, and Y.T. van der Schouw Endogenous sex hormones and progression of carotid atherosclerosis in elderly men Circulation 109 2004 2074 2079
131. R. Demirbag, R. Yilmaz, A. Ulucay, and D. Unlu The inverse relationship between thoracic aortic intima media thickness and testosterone level Endocr Res 31 2005 335 344
132. P.M. Oskui, W.J. French, M.J. Herring, G.S. Mayeda, S. Burstein, and R.A. Kloner Testosterone and the cardiovascular system: a comprehensive review of the clinical literature J Am Heart Assoc 2 2013 e000272
133. M.J. Herring, P.M. Oskui, S.L. Hale, and R.A. Kloner Testosterone and the cardiovascular system: a comprehensive review of the basic science literature J Am Heart Assoc. 2 2013 e000271
134. C. Vlachopoulos, N. Ioakeimidis, D. Terentes-Printzios, K. Aznaouridis, K. Rokkas, A. Aggelis, A. Synodinos, G. Lazaros, and C. Stefanadis Plasma total testosterone and incident cardiovascular events in hypertensive patients Am J Hypertens 26 2013 373 381
135. C. Ohlsson, E. Barrett-Connor, S. Bhasin, E. Orwoll, F. Labrie, M. Karlsson, O. Ljunggren, L. Vandenput, D. Mellstrom, and A. Tivesten High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic fractures in men) study in Sweden J Am Coll Cardiol 58 2011 1674 1682
136. S.P. Zhao, and X.P. Li The association of low plasma testosterone level with coronary artery disease in Chinese men Int J Cardiol 63 1998 161 164
137. K.M. English, O. Mandour, R.P. Steeds, M.J. Diver, T.H. Jones, and K.S. Channer Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms Eur Heart J 21 2000 890 894
138. S. Basaria, A.D. Coviello, T.G. Travison, T.W. Storer, W.R. Farwell, A.M. Jette, R. Eder, S. Tennstedt, J. Ulloor, A. Zhang, K. Choong, K.M. Lakshman, N.A. Mazer, R. Miciek, J. Krasnoff, A. Elmi, P.E. Knapp, B. Brooks, E. Appleman, S. Aggarwal, G. Bhasin, L. Hede-Brierley, A. Bhatia, L. Collins, N. LeBrasseur, L.D. Fiore, and S. Bhasin Adverse events associated with testosterone administration N Engl J Med 363 2010 109 122
139. R. Vigen, C.I. O'Donnell, A.E. Baron, G.K. Grunwald, T.M. Maddox, S.M. Bradley, A. Barqawi, G. Woning, M.E. Wierman, M.E. Plomondon, J.S. Rumsfeld, and M. Ho Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels JAMA. 310 2013 1829 1836
140. S. Dobrzycki, W. Serwatka, S. Nadlewski, J. Korecki, R. Jackowski, J. Paruk, J. Ladny, and T. Hirnle An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males J Med Invest 50 2003 162 169
141. G. Rosano, I. Sheiban, R. Massaro, P. Pgnotta, G. Marazzi, C. Vitale, G. Mercuro, M. Volterrani, A. Aversa, and M. Fini Low testosterone levels are associated with coronary artery disease in male patients with angina Int J Impot Res 19 2007 176 182
142. X. Hu, L. Rui, T. Zhu, H. Xia, X. Yang, X. Wang, H. Liu, Z. Lu, and H. Jiang Low testosterone level in middle-aged male patients with coronary artery disease Eur J Intern Med 22 2011 133 136
143. L. Li, C.Y. Guo, E.Z. Jia, T.B. Zhu, L.S. Wang, K.J. Cao, W.Z. Ma, and Z.J. Yang Testosterone is negatively associated with the severity of coronary atherosclerosis in men Asian J Androl 14 2012 875 878
144. G.B. Phillips, B.H. Pinkernell, and T.Y. Jing The association of hypotestosteronemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 14 1994 701 706
145. G.D. Smith, Y. Ben-Shlomo, A. Beswick, J. Yarnell, S. Lightman, and P. Elwood Cortisol, testosterone and coronary heart disease: prospective evidence from the Caerphilly study Circulation 112 2005 332 340
146. G.A. Laughlin, E. Barrett-Connor, and J. Bergstrom Low serum testosterone and mortality in older men J Clin Endocrinol Metab 93 2008 68 75
147. A. Tivesten, L. Vandenput, F. Labrie, M.K. Karlsson, O. Ljunggren, D. Mellstrom, and C. Ohlsson Low serum testosterone and estradiol predict mortality in elderly men J Clin Endocrinol Metab 94 2009 2482 2488
148. C.J. Malkin, P.J. Pugh, P.D. Morris, S. Asif, T.H. Jones, and K.S. Channer Low serum testosterone and increased mortality in men with coronary heart disease Heart 96 2010 1821 1825
149. R. Haring, H. Volzke, A. Steveling, A. Krebs, S.B. Felix, C. Schofl, M. Dorr, M. Nauck, and H. Wallaschofski Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79 Eur Heart J 31 2010 1494 1501
150. S. Bhasin, M. Pencina, G.K. Jasuja, T.G. Travison, A. Coviello, E. Orwoll, P.Y. Wang, C. Nielson, F. Wu, A. Tajar, F. Labrie, H. Vesper, A. Zhang, J. Ulloor, R. Singh, R. D'Agostino, and R.S. Vasan Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts J Clin Endocrinol Metab 96 2011 2430 2439
151. N.N. Stone, M. Miner, W.L. Poage, A. Patel, and D.E. Crawford Male androgen deficiency syndrome screening questionnaire: a simplified instrument to identify testosterone-deficient men J Men's health 11 2014 28 37
152. G. Hackett, N. Cole, M. Bhartia, D. Kennedy, J. Raju, P. Wilkinson, and A. Saghir BLAST STUDY GROUP. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study) Int J Clin Pract 2013
153. J.S. Finkelstein, H. Lee, S.A. Burnett-Bowie, J.C. Pallais, E.W. Yu, L.F. Borges, B.F. Jones, C.V. Barry, K.E. Wulczyn, B.J. Thomas, and B.Z. Leder Gonadal steroids and body composition, strength, and sexual function in men N Engl J Med 369 2013 1011 1022
154. Shi MD, Chao JK, Ma MC, Hao LJ, Chao IC. Factors Associated with Sex Hormones and Erectile Dysfunction in Male Taiwanese Participants with Obesity. J Sex Med 2013 Oct 31.
155. Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P; BLAST study group. testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study. J Sex Med 2013.
156. E. García-Cruz, A. Leibar-Tamayo, J. Romero, M. Piqueras, P. Luque, O. Cardeñosa, and A. Alcaraz Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction J Sex Med 10 2013 2529 2538
157. A. HamidiMadani, A. Heidarzadeh, N. AkbariParsa, F. KhosraviDarestani, and Z. HamidiMadani A survey on relative frequency of metabolic syndrome and testosterone deficiency in men with erectile dysfunction Int Urol Nephrol 44 2012 667 672
158. J. Kang 2nd, B.K. Ham, M.M. Oh, J.J. Kim, and G. Moon du Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome Korean J Urol. 52 2011 416 420
159. B.C. Jacob Testosterone replacement therapy in males with erectile dysfunction J Pharm Pract 24 2011 298 306
160. A. Morales Androgens are fundamental in the maintenance of male sexual health Curr Urol Rep 12 2011 453 460
161. A.M. Traish, I. Goldstein, and N.N. Kim Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction Eur Urol 52 2007 54 70
162. F. Saad, A.S. Grahl, A. Aversa, A.A. Yassin, A. Kadioglu, I. Moncada, and I. Eardley Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction BJU Int 99 2007 988 992
163. E.R. Boloña, M.V. Uraga, R.M. Haddad, M.J. Tracz, K. Sideras, C.C. Kennedy, S.M. Caples, P.J. Erwin, and V.M. Montori Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials Mayo Clin Proc 82 2007 20 28
164. M.D. Mitkov, I.Y. Aleksandrova, and M.M. Orbetzova Effect of transdermal testosterone or alpha-lipoic acid on erectile dysfunction and quality of life in patients with type 2 diabetes mellitus Folia Med (Plovdiv) 55 2013 55 63
165. C.A. Allan, E.A. Forbes, B.J. Strauss, and R.I. McLachlan Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency Int J Impot Res 20 2008 396 401
166. A.M. Isidori, J. Buvat, G. Corona, I. Goldstein, E.A. Jannini, A. Lenzi, H. Porst, A. Salonia, A.M. Traish, and M. Maggi A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review Eur Urol 65 2014 99 112
167. P. Mårin, M. Krotkiewski, and P. Björntorp Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues Eur J Med. 1 1992 329 336
168. C.A. Allan, B.J. Strauss, H.G. Burger, E.A. Forbes, and R.I. McLachlan Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in non-obese aging men J Clin Endocrinol Metab 93 2008 139 146
169. U. Srinivas-Shankar, S.A. Roberts, M.J. Connolly, M.D. O'Connell, J.E. Adams, J.A. Oldham, and F.C. Wu Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study J Clin Endocrinol Metab 95 2010 639 650
170. G. Caminiti, M. Volterrani, F. Iellamo, G. Marazzi, R. Massaro, M. Miceli, C. Mammi, M. Piepoli, M. Fini, and G.M. Rosano Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study J Am Coll Cardiol 54 2009 919 927
171. S. Bhasin, L. Woodhouse, R. Casaburi, A.B. Singh, R.P. Mac, M. Lee, K.E. Yarasheski, I. Sinha-Hikim, C. Dzekov, J. Dzekov, L. Magliano, and T.W. Storer Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle J Clin Endocrinol Metab 90 2005 678 688
172. J. Svartberg, I. Agledahl, Y. Figenschau, T. Sildnes, K. Waterloo, and R. Jorde Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip Int J Impot Res 20 2008 378 387
173. S.Y. Kalinchenko, Y.A. Tishova, G.J. Mskhalaya, L.J. Gooren, E.J. Giltay, and F. Saad Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study Clin Endocrinol (Oxf) 73 2010 602 612
174. H.M. Behre, T.L. Tammela, S. Arver, J.R. Tolrá, V. Bonifacio, M. Lamche, and J. Kelly Hiemeyer F; European Testogel® Study Team, Giltay EJ, Gooren LJ. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up Aging Male 15 2012 198 207
175. M.H. Emmelot-Vonk, H.J. Verhaar, and H.R. NakhaiPour et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial JAMA 299 2008 39 52
176. J. Svartberg, I. Agledahl, Y. Figenschau, T. Sildnes, K. Waterloo, and R. Jorde Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip Int J Impot Res 20 2008 378 387
177. P.J. Snyder, H. Peachey, and P. Hannoush et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age J Clin Endocrinol Metab 84 1999 2647 2653
178. A.M. Kenny, K.M. Prestwood, C.A. Gruman, K.M. Marcello, and L.G. Raisz Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels J Gerontol A Biol Sci Med Sci 56 2001 M266 M272
179. A.A. Ferrando, M. Sheffield-Moore, and C.W. Yeckel et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms Am J Physiol Endocrinol Metab 282 2002 E601 E607
180. C. Wang, R.S. Swerdloff, and A. Iranmanesh et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men J Clin Endocrinol Metab 85 2000 2839 2853
181. A. Aversa, R. Bruzziches, D. Francomano, E.A. Greco, R. Fornari, L. Di Luigi, A. Lenzi, and S. Migliaccio Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study Aging Male 15 2012 96 102
182. Yarrow JF, Conover CF, Beggs LA, Beck DT, Otzel DM, Balaez A, Combs SM, Miller JR, Ye F, Aguirre JI, Neuville KG, Williams AA, Conrad BP, Gregory CM, Wronski TJ, Bose PK, Borst SE. Testosterone dose-dependently prevents bone and muscle loss in rodents following spinal cord injury. J Neurotrauma. 2013 Dec 30.
183. Kacker R, Conners W, Zade J, Morgentaler A. Bone Mineral Density and Response to Treatment in Men Less Than Fifty Years With Testosterone Deficiency and Sexual Dysfunction or Infertility. J Urol. 2013 (in press).
184. D.G. Jo, H.S. Lee, Y.M. Joo, and J.T. Seo Effect of testosterone replacement therapy on bone mineral density in patients with Klinefelter syndrome Yonsei Med J 54 2013 1331 1335
185. Duarte RV, Raphael JH, Southall JL, Labib MH, Whallett AJ, Ashford RL. Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy. BMJ Open. 2013;3.
186. J. Rodriguez-Tolrà, J. Torremadé, S. di Gregorio, L. Del Rio, and E. Franco Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome Andrology 1 2013 570 575
187. P.M. Bouloux, J.J. Legros, J.M. Elbers, T.B. Geurts, M.J. Kaspers, and A.G. Meehan Meuleman EJ; Study 43203 Investigators. Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study Aging Male 16 2013 38 47
188. P. Deb, S.K. Gupta, and M.M. Godbole Effects of short-term testosterone replacement on areal bone mineral density and bone turnover in young hypogonadal males Indian J Endocrinol Metab 16 2012 947 951
189. K.Y. Chin, I.N. Soelaiman, I. Naina Mohamed, S. Shahar, N.I. Teng, E. Suhana Mohd Ramli, F. Ahmad, A. Aminuddin, and W. Zurinah Wan Ngah Testosterone is associated with age-related changes in bone health status, muscle strength and body composition in men Aging Male 15 2012 240 145
190. B. Yang, H. Sun, Y. Wan, H. Wang, W. Qin, L. Yang, H. Zhao, J. Yuan, and B. Yao Associations between testosterone, bone mineral density, vitamin D and semen quality in fertile and infertile Chinese men Int J Androl 35 2012 783 792
191. E.M. Laitinen, M. Hero, K. Vaaralahti, J. Tommiska, and T. Raivio Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism Int J Androl 35 2012 534 540
192. Y.J. Wang, J.K. Zhan, W. Huang, Y. Wang, Y. Liu, S. Wang, P. Tan, Z.Y. Tang, and Y.S. Liu Effects of low-dose testosterone undecanoate treatment on bone mineral density and bone turnover markers in elderly male osteoporosis with low serum testosterone Int J Endocrinol 2013 2013 570413
193. D.H. De Oliveira, T.M. Fighera, L.C. Bianchet, C.A. Kulak, and J. Kulak Androgens and bone Minerva Endocrinol 37 2012 305 314
194. E. Garcia-Cruz, M. Piqueras, J. Huguet, M. Perez-Marquez, D. Gosalbez, L. Peri, L. Izquierdo, P. Luque, M.J. Ribal, and A. Alcaraz Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy Int J Impot Res 24 2012 110 113
195. C.C. Ho, S.F. Tong, W.Y. Low, C.J. Ng, E.M. Khoo, V.K. Lee, Z.M. Zainuddin, and H.M. Tan A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale BJU Int 110 2012 260 265
196. A. Tsujimura The Relationship between Testosterone Deficiency and Men's Health World J Mens Health 31 2013 126 135
197. S.N. Seidman, and M. Weiser Testosterone and mood in aging men Psychiatr Clin North Am 36 2013 177 182
198. A. Tajar, I.T. Huhtaniemi, T.W. O'Neill, J.D. Finn, S.R. Pye, D.M. Lee, G. Bartfai, S. Boonen, F.F. Casanueva, G. Forti, A. Giwercman, T.S. Han, K. Kula, F. Labrie, M.E. Lean, N. Pendleton, M. Punab, D. Vanderschueren, and F.C. Wu EMAS group. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS) J Clin Endocrinol Metab 97 2012 1508 1516
199. C. Cattabiani, S. Basaria, G.P. Ceda, M. Luci, A. Vignali, F. Lauretani, G. Valenti, R. Volpi, and M. Maggio Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men J Endocrinol Invest. 35 2012 104 120
200. B.B. Yeap Testosterone and sex in older men Med J Aust 195 2011 61 62
201. B.B. Yeap Are declining testosterone levels a major risk factor for ill-health in aging men? Int J Impot Res 21 2009 24 36
202. G. Corona, G. Rastrelli, G. Forti, and M. Maggi Update in testosterone therapy for men J Sex Med 8 2011 639 654
203. M.I. Ullah, T. Washington, M. Kazi, S. Tamanna, and C.A. Koch Testosterone deficiency as a risk factor for cardiovascular disease Horm Metab Res 43 2011 153 164
204. J.J. Naghi, K.J. Philip, D. DiLibero, R. Willix, and E.R. Schwarz Testosterone therapy: treatment of metabolic disturbances in heart failure J Cardiovasc Pharmacol Ther 16 2011 14 23
205. R. Tamler, and T. Deveney Hypogonadism, erectile dysfunction, and type 2 diabetes mellitus: what the clinician needs to know Postgrad Med 122 2010 165 175
206. Glintborg D, Nielsen TL, Wraae K, Hougaard D, Gudex C, Brixen K, Andersen M. The relationship between health-related quality of life, obesity and testosterone levels in older men. Age Ageing. 2013 Dec 29.
207. Morales A. Testosterone Deficiency Syndrome: An overview with emphasis on the diagnostic conundrum. Clin Biochem. 2013 Dec 16.
208. Lašaite L, Ceponis J, Preikša RT, Zilaitiene B Impaired emotional state, quality of life and cognitive functions in young hypogonadal men. Andrologia. 2013 Dec 8.
209. Pexman-Fieth C, Behre HM, Morales A, Kan-Dobrosky N, Miller MG. A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. Aging Male 2013 Nov 25.
210. A.K. Bello, P. Stenvinkel, M. Lin, B. Hemmelgarn, R. Thadhani, S. Klarenbach, C. Chan, D. Zimmerman, G. Cembrowski, G. Strippoli, J.J. Carrero, and M. Tonelli Serum testosterone levels and clinical outcomes in male hemodialysis patients Am J Kidney Dis S0272-6386 13 2013 00985-2
211. J.A. Pearl, D. Berhanu, N. François, P. Masson, S. Zargaroff, J. Cashy, and K.T. McVary Testosterone supplementation does not worsen lower urinary tract symptoms J Urol. 190 2013 1828 1833
212. E. Del Fabbro, J.M. Garcia, R. Dev, D. Hui, J. Williams, D. Engineer, J.L. Palmer, L. Schover, and E. Bruera Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial Support Care Cancer 21 2013 2599 2607
213. J. Khoo, H.H. Tian, B. Tan, K. Chew, C.S. Ng, D. Leong, R.C. Teo, and R.Y. Chen Comparing effects of low- and high-volume moderate-intensity exercise on sexual function and testosterone in obese men J Sex Med 10 2013 1823 1832
214. G. Hackett, N. Cole, M. Bhartia, D. Kennedy, J. Raju, and P. Wilkinson Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes J Sex Med 10 2013 1612 1627
215. F. Strollo, G. Strollo, M. Morè, P. Magni, C. Macchi, M.A. Masini, I. Carucci, F. Celotti, M. Ruscica, and S. Gentile Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients Aging Male 16 2013 33 37
216. M. Stout, G.A. Tew, H. Doll, I. Zwierska, N. Woodroofe, K.S. Channer, and J.M. Saxton Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study Am Heart J 164 2012 893 901
217. R.K. Bhattacharya, M. Khera, G. Blick, H. Kushner, and M.M. Miner Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS) Clin Interv Aging 7 2012 321 330
218. M. Amore, M. Innamorati, S. Costi, L. Sher, P. Girardi, and M. Pompili Partial androgen deficiency, depression, and testosterone supplementation in aging men Int J Endocrinol 2012 2012 280724
219. S.F. Tong, C.J. Ng, B.C. Lee, V.K. Lee, E.M. Khoo, E.G. Lee, and H.M. Tan Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial Asian J Androl 14 2012 604 611
220. R. Amiaz, H.G. Pope Jr, T. Mahne, J.F. Kelly, B.P. Brennan, G. Kanayama, M. Weiser, J.I. Hudson, and S.N. Seidman Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial J Sex Marital Ther 37 2011 243 254
221. W.P. Conners 3rd, and A. Morgentaler The evaluation and management of testosterone deficiency: the new frontier in urology and men's health Curr Urol Rep 14 2013 557 564
222. Y. Kido, S. Sakazume, Y. Abe, Y. Oto, H. Itabashi, M. Shiraishi, A. Yoshino, Y. Tanaka, K. Obata, N. Murakami, and T. Nagai Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader-Willi syndrome: an observational study Am J Med Genet A 161 2013 2167 2173
223. Traish AM, Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II. Steroids 2014;88:117-26.